Skip to main content

Client News

Formycon and MS Pharma sign exclusive commercialization partnership for Keytruda® biosimilar candidate FYB206 for the MENA Region

4th December 2025

DoctorBox Adds Mainz Biomed’s ColoAlert® to Its Portfolio DNA-based Colorectal Cancer Screening as a Home Test

2nd December 2025

Rentschler Biopharma and Coriolis Pharma announce strategic collaboration for integrated biopharma solutions

2nd December 2025

Tacalyx Appoints Jean Engela as Chief Executive Officer to Spearhead Next Phase of Growth

2nd December 2025

CARBIOS and Wankai New Materials sign the definitive agreement establishing a strategic partnership to the large-scale deployment of CARBIOS’s PET biorecycling technology in Asia

2nd December 2025

AFYREN raises €23 million through share capital increase to finance optimization and expansion of unique biorefinery AFYREN NEOXY

26th November 2025

CARBIOS signs two new multi-year commercial agreements for recycled PET with major players in the beverage industry

24th November 2025

Heidelberg Pharma Announces Changes to the Executive Management Board – Dr Dongzhou Jeffery Liu Appointed as Chairman of the Executive Board and Chief Executive Officer

24th November 2025

MIG Capital, via its MIG Fonds, Leads €16 Million Seed Financing for AI Hardware Startup NcodiN

20th November 2025

Mainz Biomed and OncoVanguard8 Enter into Agreement to bring ColoAlert to South America

18th November 2025